Finance

Beta
Lists
CAH:NYSE
Cardinal Health Inc
$197.06
+1.12%
(+2.18) 1D
Jun 3, 9:58:45 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CAH...
Open
$196.09
High
$198.07
Low
$195.92
Mkt. cap
46.15B
Avg. vol.
2.35M
Volume
95.61K
Dividend
1.05%
Quarterly dividend
$0.52
Ex-dividend date
Jul 1, 2026
P/E ratio
30.11
52-wk high
$233.60
52-wk low
$137.75
EPS
$6.54
Beta
0.52
Shares outstanding
234.21M
No. of employees
55K
Open
$196.09
High
$198.07
Low
$195.92
Mkt. cap
46.15B
Avg. vol.
2.35M
Volume
95.61K
Dividend
1.05%
Quarterly dividend
$0.52
Ex-dividend date
Jul 1, 2026
P/E ratio
30.11
52-wk high
$233.60
52-wk low
$137.75
EPS
$6.54
Beta
0.52
Shares outstanding
234.21M
No. of employees
55K
News stories
From sources across the web
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health Inc
CEOJason Hollar
Employees55.4K
Founded1971
HeadquartersDublin, Ohio, United States
SectorHealth care provider
Websitecardinalhealth.com
Last report
Apr 30, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$3.17 / $2.79
+13.70%beat
Revenue / Est. (USD)
60.94B / 62.30B
-2.19%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
60.16B
64.01B
65.63B
60.94B
Cost of goods sold
57.96B
61.69B
63.23B
58.44B
Cost of revenue
57.96B
61.69B
63.23B
58.44B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.48B
1.46B
1.50B
1.54B
Operating expense
1.57B
1.55B
1.59B
1.64B
Total operating expenses
59.53B
63.24B
64.82B
60.08B
Operating income
629.00M
771.00M
809.00M
861.00M
Other non operating income
20.00M
10.00M
11.00M
-16.00M
EBT including unusual items
384.00M
598.00M
630.00M
392.00M
EBT excluding unusual items
585.00M
701.00M
732.00M
744.00M
Income tax expense
141.00M
144.00M
159.00M
12.00M
Effective tax rate
36.72%
24.08%
25.24%
3.06%
Other operating expenses
-
-
-
-
Net income
239.00M
450.00M
467.00M
399.00M
Net profit margin
0.40%
0.70%
0.71%
0.65%
Earnings per share
2.08
2.55
2.63
3.17
Interest and investment income
-
-
-
-
Interest expense
-41.00M
-80.00M
-88.00M
-101.00M
Net interest expenses
-41.00M
-80.00M
-88.00M
-101.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
838.00M
1.00B
1.04B
1.11B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer